IDXX
IDEXX Laboratories, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-20
Figures on this page computed 2026-11-08 12:33 UTC
Last close
698.55USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-20
51.3xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
54.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
24.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
24.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
0.36Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Price is the furthest below its sector's middle: 0.09 against 0.36 on the market's range.
- Growth9.7%59 of 100, above its sector
- Returns on capital54.3%98 of 100, above its sector
- Margins61.8%88 of 100, above its sector
- Price51.3x9 of 100, below its sector
- Safety0.3669 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
5 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-02-20
- Sales1.46x
Its own average over 10 years, 2.95B.
- Profit1.74x
Its own average over 10 years, 608.8M.
- Free cash flow1.97x
Its own average over 10 years, 537.1M.
- Debt0.76x
Its own average over 10 years, 756.8M.
- Price1.76x
Its own average over 11 years, 397. Market data, 2026-11-04
Free cash flow is furthest from its own average, at 1.97 times.
Sales is 1.46 times its own 10-year average; Profit is 1.74 times its own 10-year average; Free cash flow is 1.97 times its own 10-year average; Debt is 0.76 times its own 10-year average; Price is 1.76 times its own 11-year average.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-20
Sales against its own 10-year average1.46
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Profit against its own 10-year average1.74
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Free cash flow against its own 10-year average1.97
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Debt against its own 10-year average0.76
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Price against its own 11-year average1.76Market data, 2026-11-04
- Source
- market
- Taken on
- 2026-11-04
- Reported in
- USD